These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33438446)

  • 1. Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer.
    Zou X; Jiang Z; Li L; Huang Z
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):83-95. PubMed ID: 33438446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of novel ruthenium loaded silk fibroin nanomaterials for fingolimod release improved antitumor efficacy in hepatocellular carcinoma.
    Li D; Xia C; Chen X; Li Q; Li J; Qian X
    J Biomater Sci Polym Ed; 2022 Oct; 33(15):1955-1972. PubMed ID: 35820069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery.
    Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B
    ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
    Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
    Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic cRGDfk peptide and Chlorin e6 functionalized silk fibroin nanoparticles for targeted drug delivery and photodynamic therapy.
    Mao B; Liu C; Zheng W; Li X; Ge R; Shen H; Guo X; Lian Q; Shen X; Li C
    Biomaterials; 2018 Apr; 161():306-320. PubMed ID: 29427926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
    Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
    ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth.
    Wu P; Liu Q; Wang Q; Qian H; Yu L; Liu B; Li R
    Int J Nanomedicine; 2018; 13():5405-5418. PubMed ID: 30271137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
    Wu JY; Wang ZX; Zhang G; Lu X; Qiang GH; Hu W; Ji AL; Wu JH; Jiang CP
    Int J Nanomedicine; 2018; 13():1265-1280. PubMed ID: 29551896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
    Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
    Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer.
    Niemelä E; Desai D; Niemi R; Doroszko M; Özliseli E; Kemppainen K; Rahman NA; Sahlgren C; Törnquist K; Eriksson JE; Rosenholm JM
    Eur J Pharm Biopharm; 2020 Mar; 148():1-9. PubMed ID: 31917332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo.
    Xia Y; Tang G; Guo M; Xu T; Chen H; Lin Z; Li Y; Chen Y; Zhu B; Liu H; Cao J
    Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110594. PubMed ID: 32204058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
    Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
    Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer.
    Moin A; Wani SUD; Osmani RA; Abu Lila AS; Khafagy ES; Arab HH; Gangadharappa HV; Allam AN
    Drug Deliv; 2021 Dec; 28(1):1626-1636. PubMed ID: 34328806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the
    Rezaie Shirmard L; Ghofrani M; Bahari Javan N; Bayrami S; Tavassoli A; Rezaie A; Amini M; Kebriaee-Zadeh A; Rouini MR; Dinarvand R; Rafiee-Tehrani M; Dorkoosh FA
    Drug Dev Ind Pharm; 2020 Feb; 46(2):318-328. PubMed ID: 31976771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MnO
    Zhang L; Yang R; Yu H; Xu Z; Kang Y; Cui H; Xue P
    J Mater Chem B; 2021 May; 9(17):3677-3688. PubMed ID: 33949613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.
    Alshaker H; Wang Q; Srivats S; Chao Y; Cooper C; Pchejetski D
    Breast Cancer Res Treat; 2017 Oct; 165(3):531-543. PubMed ID: 28695300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
    Luo F; Fan Z; Yin W; Yang L; Li T; Zhong L; Li Y; Wang S; Yan J; Hou Z; Zhang Q
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110107. PubMed ID: 31546448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized silk fibroin nanoparticle functionalization with anti-CEA nanobody enhancing active targeting of colorectal cancer cells.
    Fan X; Peng X; Wang T; Gu Y; Sun G; Shou Q; Song H; Nian R; Liu W
    Biomed Mater; 2023 Jun; 18(4):. PubMed ID: 37321227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.